QQQ   445.58 (+-0.01%)
AAPL   174.53 (-2.86%)
MSFT   415.10 (-0.10%)
META   500.66 (-0.33%)
GOOGL   133.09 (-2.95%)
AMZN   179.95 (+0.97%)
TSLA   191.60 (-5.45%)
NVDA   854.47 (+3.85%)
NIO   5.42 (-6.23%)
AMD   209.62 (+3.44%)
BABA   72.18 (-3.27%)
T   16.94 (-0.24%)
F   12.95 (+4.02%)
MU   96.04 (+0.94%)
CGC   3.04 (-5.30%)
GE   159.97 (+0.83%)
DIS   113.26 (+1.17%)
AMC   4.36 (+0.00%)
PFE   25.84 (-2.82%)
PYPL   59.40 (-1.88%)
XOM   104.80 (-0.98%)
QQQ   445.58 (+-0.01%)
AAPL   174.53 (-2.86%)
MSFT   415.10 (-0.10%)
META   500.66 (-0.33%)
GOOGL   133.09 (-2.95%)
AMZN   179.95 (+0.97%)
TSLA   191.60 (-5.45%)
NVDA   854.47 (+3.85%)
NIO   5.42 (-6.23%)
AMD   209.62 (+3.44%)
BABA   72.18 (-3.27%)
T   16.94 (-0.24%)
F   12.95 (+4.02%)
MU   96.04 (+0.94%)
CGC   3.04 (-5.30%)
GE   159.97 (+0.83%)
DIS   113.26 (+1.17%)
AMC   4.36 (+0.00%)
PFE   25.84 (-2.82%)
PYPL   59.40 (-1.88%)
XOM   104.80 (-0.98%)
QQQ   445.58 (+-0.01%)
AAPL   174.53 (-2.86%)
MSFT   415.10 (-0.10%)
META   500.66 (-0.33%)
GOOGL   133.09 (-2.95%)
AMZN   179.95 (+0.97%)
TSLA   191.60 (-5.45%)
NVDA   854.47 (+3.85%)
NIO   5.42 (-6.23%)
AMD   209.62 (+3.44%)
BABA   72.18 (-3.27%)
T   16.94 (-0.24%)
F   12.95 (+4.02%)
MU   96.04 (+0.94%)
CGC   3.04 (-5.30%)
GE   159.97 (+0.83%)
DIS   113.26 (+1.17%)
AMC   4.36 (+0.00%)
PFE   25.84 (-2.82%)
PYPL   59.40 (-1.88%)
XOM   104.80 (-0.98%)
QQQ   445.58 (+-0.01%)
AAPL   174.53 (-2.86%)
MSFT   415.10 (-0.10%)
META   500.66 (-0.33%)
GOOGL   133.09 (-2.95%)
AMZN   179.95 (+0.97%)
TSLA   191.60 (-5.45%)
NVDA   854.47 (+3.85%)
NIO   5.42 (-6.23%)
AMD   209.62 (+3.44%)
BABA   72.18 (-3.27%)
T   16.94 (-0.24%)
F   12.95 (+4.02%)
MU   96.04 (+0.94%)
CGC   3.04 (-5.30%)
GE   159.97 (+0.83%)
DIS   113.26 (+1.17%)
AMC   4.36 (+0.00%)
PFE   25.84 (-2.82%)
PYPL   59.40 (-1.88%)
XOM   104.80 (-0.98%)

IM Cannabis (IMCC) Competitors

$0.33
0.00 (-0.91%)
(As of 10:22 AM ET)

IMCC vs. MTEX, FWBI, BSGM, KZIA, OPGN, THAR, GOVX, AVGR, BPTS, and AEMD

Should you be buying IM Cannabis stock or one of its competitors? The main competitors of IM Cannabis include Mannatech (MTEX), First Wave BioPharma (FWBI), BioSig Technologies (BSGM), Kazia Therapeutics (KZIA), OpGen (OPGN), Tharimmune (THAR), GeoVax Labs (GOVX), Avinger (AVGR), Biophytis (BPTS), and Aethlon Medical (AEMD). These companies are all part of the "medical" sector.

IM Cannabis vs.

IM Cannabis (NASDAQ:IMCC) and Mannatech (NASDAQ:MTEX) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, analyst recommendations, risk, valuation, institutional ownership, community ranking, earnings and media sentiment.

IM Cannabis has a net margin of 0.00% compared to Mannatech's net margin of -5.62%. IM Cannabis' return on equity of 21.99% beat Mannatech's return on equity.

Company Net Margins Return on Equity Return on Assets
IM CannabisN/A 21.99% 8.74%
Mannatech -5.62%-59.58%-16.01%

IM Cannabis has a beta of 0.85, meaning that its stock price is 15% less volatile than the S&P 500. Comparatively, Mannatech has a beta of 1.21, meaning that its stock price is 21% more volatile than the S&P 500.

In the previous week, IM Cannabis had 2 more articles in the media than Mannatech. MarketBeat recorded 5 mentions for IM Cannabis and 3 mentions for Mannatech. IM Cannabis' average media sentiment score of 1.06 beat Mannatech's score of 0.62 indicating that IM Cannabis is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
IM Cannabis
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Mannatech
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

9.9% of IM Cannabis shares are owned by institutional investors. Comparatively, 24.3% of Mannatech shares are owned by institutional investors. 53.1% of Mannatech shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Mannatech received 267 more outperform votes than IM Cannabis when rated by MarketBeat users. Likewise, 74.18% of users gave Mannatech an outperform vote while only 42.86% of users gave IM Cannabis an outperform vote.

CompanyUnderperformOutperform
IM CannabisOutperform Votes
6
42.86%
Underperform Votes
8
57.14%
MannatechOutperform Votes
273
74.18%
Underperform Votes
95
25.82%

Mannatech has higher revenue and earnings than IM Cannabis.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IM Cannabis$41.79M0.10-$145.29MN/AN/A
Mannatech$137.21M0.12-$4.49M-$4.04-2.22

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IM Cannabis
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Mannatech
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Summary

Mannatech beats IM Cannabis on 8 of the 13 factors compared between the two stocks.


Get IM Cannabis News Delivered to You Automatically

Sign up to receive the latest news and ratings for IMCC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IMCC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IMCC vs. The Competition

MetricIM CannabisMedicinals & botanicals IndustryMedical SectorNASDAQ Exchange
Market Cap$4.36M$1.14B$4.79B$7.55B
Dividend YieldN/A4.45%5.36%3.87%
P/E RatioN/A3.58178.8514.86
Price / Sales0.103.072,977.9580.58
Price / CashN/A8.5032.0828.74
Price / Book0.132.374.524.72
Net Income-$145.29M-$171.50M$110.02M$211.52M
7 Day Performance1.34%3.75%114.57%3.78%
1 Month Performance33.02%1.10%125.65%8.91%
1 Year Performance-62.51%-9.40%133.16%8.68%

IM Cannabis Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MTEX
Mannatech
0.7927 of 5 stars
$8.66
-2.4%
N/A-48.7%$16.11M$137.21M-2.14228
FWBI
First Wave BioPharma
3.0274 of 5 stars
$6.85
+15.3%
$120.00
+1,651.8%
-87.6%$4.66MN/A-0.0310News Coverage
BSGM
BioSig Technologies
0 of 5 stars
$0.51
+6.3%
N/A-93.9%$4.58M$141,000.00-0.1147Short Interest ↑
High Trading Volume
KZIA
Kazia Therapeutics
3.4469 of 5 stars
$0.28
-6.7%
$2.00
+616.8%
-77.1%$4.56M$20,000.000.002,021
OPGN
OpGen
0.4324 of 5 stars
$0.48
+4.3%
N/A-46.9%$4.83M$2.61M-0.0785
THAR
Tharimmune
2.7222 of 5 stars
$0.41
+7.9%
N/AN/A$4.83MN/A-0.031Positive News
Gap Up
GOVX
GeoVax Labs
3.0201 of 5 stars
$2.71
+14.8%
$90.00
+3,221.0%
-77.7%$4.83M$80,000.00-0.2014Short Interest ↑
High Trading Volume
AVGR
Avinger
2.0696 of 5 stars
$3.53
+2.3%
$5.00
+41.6%
-78.6%$4.84M$8.27M-0.1171Short Interest ↑
Gap Down
BPTS
Biophytis
2.8926 of 5 stars
$0.50
-3.8%
$15.00
+2,900.0%
-91.7%$4.87MN/A0.0026Short Interest ↓
Gap Down
AEMD
Aethlon Medical
2.581 of 5 stars
$1.71
-2.3%
$23.00
+1,245.0%
-64.2%$4.48M$570,000.00-0.3415Analyst Report
Short Interest ↓

Related Companies and Tools

This page (NASDAQ:IMCC) was last updated on 3/4/2024 by MarketBeat.com Staff